Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.42 USD | -2.03% | -2.05% | +2.04% |
Apr. 18 | Oppenheimer Raises Avient Price Target to $49 From $45, Maintains Outperform Rating | MT |
Feb. 15 | Deutsche Bank Adjusts Avient Price Target to $42 From $37, Maintains Hold Rating | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- With a 2024 P/E ratio at 26.68 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.04% | 3.95B | A- | ||
+14.02% | 63.38B | A- | ||
-3.80% | 46.51B | A- | ||
+13.26% | 39.91B | B+ | ||
+18.47% | 25.57B | A- | ||
+8.22% | 18.95B | C+ | ||
-1.13% | 17.58B | B+ | ||
-21.03% | 16.1B | A- | ||
+1.06% | 14.98B | B+ | ||
-16.73% | 14.78B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AVNT Stock
- Ratings Avient Corporation